SUE-LAY PLASENCIA: Open Payments
NPI 1285248195 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 18 payments from 7 companies in 2025. Trend: 2023 $783 · 2024 $469 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $129 |
| GENZYME CORPORATION | 3 | $117 |
| Inspire Medical Systems, Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Organogenesis Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: DUPIXENT, INSPIRE, NUCALA, Ryaltris, JOURNAVX, VIA MATRIX, PURAPLY WOUND MATRIX.
Industry payments across FL — which companies pay providers there.
